Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Your real estate tax status as a dealer or investor impacts tax rates. Learn key IRS factors, court cases and tax strategies to minimize liabilities.
PodcastDiscover how low-basis opportunities reshape real estate projects through redevelopment, adaptive reuse and mixed-use innovation.
Gain insights into 2025’s economic outlook, including job market trends, inflation and the impact of regulatory changes.
Get ahead of the curve by looking back at emerging trends in 2024 that are likely to impact health care valuation in 2025 and beyond. Download Weaver Insights now.
The shortage of key health care providers is impacting health care services. We explore factors driving demand and how this affects valuations.
Strategic property basis allocation focusing on land and building depreciation enhances real estate value while maximizing tax benefits for investors.
Fund managers planning to use convertible notes as an investment strategy must also understand the tax implications. Explore the key considerations.
Management fee waivers and cashless contributions offer tax efficiencies for fund managers, but planning is essential to avoid compliance risks.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
Zach Anderson and Meghan Matthews discuss how investment fund blockers help foreign and tax-exempt investors with tax obligations and fund operations.
KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.
Rising physician compensation and growing financial losses are putting health systems under pressure. Explore the 2024 trends and valuation insights.
